Overview Financials News + Filings Key Docs Charts Ownership Insiders
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
Quarterly results
|
|
Dare Bioscience, Inc. (DARE)
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 01/26/2023 |
4
| JOHNSON SABRINA MARTUCCI (Chef Executive Officer) has filed a Form 4 on Dare Bioscience, Inc.|
Txns:
| Granted 750,000 options to buy
@ $1.16, valued at
$870k
|
|
| 01/26/2023 |
4
| Walters-Hoffert Lisa (CFO) has filed a Form 4 on Dare Bioscience, Inc.|
Txns:
| Granted 290,000 options to buy
@ $1.16, valued at
$336.4k
|
|
| 01/26/2023 |
4
| Fair John A (Chief Commercial Officer) has filed a Form 4 on Dare Bioscience, Inc.|
Txns:
| Granted 290,000 options to buy
@ $1.16, valued at
$336.4k
|
|
| 06/24/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/24/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/24/2022 |
4
| Matz Gregory W (Director) has filed a Form 4 on Dare Bioscience, Inc.|
Txns:
| Granted 38,000 options to buy
@ $1.31, valued at
$49.8k
|
|
| 06/24/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/24/2022 |
4
| Grossman Jessica D. (Director) has filed a Form 4 on Dare Bioscience, Inc.|
Txns:
| Granted 38,000 options to buy
@ $1.31, valued at
$49.8k
|
|
| 06/24/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/24/2022 |
4
| Kelley Susan L. (Director) has filed a Form 4 on Dare Bioscience, Inc.|
Txns:
| Granted 38,000 options to buy
@ $1.31, valued at
$49.8k
|
|
| 01/28/2022 |
4
| Fair John A (Chief Strategy Officer) has filed a Form 4 on Dare Bioscience, Inc.|
Txns:
| Granted 185,000 options to buy
@ $1.59, valued at
$294.2k
|
|
| 01/28/2022 |
4
| JOHNSON SABRINA MARTUCCI (Chef Executive Officer) has filed a Form 4 on Dare Bioscience, Inc.|
Txns:
| Granted 628,400 options to buy
@ $1.59, valued at
$999.2k
|
|
| 01/28/2022 |
4
| Walters-Hoffert Lisa (CFO) has filed a Form 4 on Dare Bioscience, Inc.|
Txns:
| Granted 185,000 options to buy
@ $1.59, valued at
$294.2k
|
|
| 06/24/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/24/2021 |
4
| Matz Gregory W (Director) has filed a Form 4 on Dare Bioscience, Inc.|
Txns:
| Granted 30,000 options to buy
@ $1.46, valued at
$43.8k
|
|
| 06/24/2021 |
4
| Kelley Susan L. (Director) has filed a Form 4 on Dare Bioscience, Inc.|
Txns:
| Granted 30,000 options to buy
@ $1.46, valued at
$43.8k
|
|
| 06/24/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/24/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/24/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 04/20/2021 |
4
| Ononye-Onyia Sophia Nnenna (Director) has filed a Form 4 on Dare Bioscience, Inc.|
Txns:
| Granted 45,000 options to buy
@ $1.4, valued at
$63k
|
|
| 01/28/2021 |
4
| Fair John A (Chief Strategy Officer) has filed a Form 4 on Dare Bioscience, Inc.|
Txns:
| Granted 168,000 options to buy
@ $2.59, valued at
$435.1k
|
|
| 01/28/2021 |
4
| Walters-Hoffert Lisa (CFO) has filed a Form 4 on Dare Bioscience, Inc.|
Txns:
| Granted 168,000 options to buy
@ $2.59, valued at
$435.1k
|
|
| 01/28/2021 |
4
| JOHNSON SABRINA MARTUCCI (Chef Executive Officer) has filed a Form 4 on Dare Bioscience, Inc.|
Txns:
| Granted 525,000 options to buy
@ $2.59, valued at
$1.4M
|
|
| 06/26/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/26/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/26/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/26/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/26/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/26/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 03/09/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 03/09/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 03/09/2020 |
4
| Walters-Hoffert Lisa (CFO) has filed a Form 4 on Dare Bioscience, Inc.|
Txns:
| Granted 68,000 options to buy
@ $1.03, valued at
$70k
|
|
| 11/21/2019 |
4
| Blanchard Cheryl R (Director) has filed a Form 4 on Dare Bioscience, Inc.|
Txns:
| Granted 45,000 options to buy
@ $0.79, valued at
$35.6k
|
|
| 06/14/2019 |
4
| Kelley Susan L. (Director) has filed a Form 4 on Dare Bioscience, Inc.|
Txns:
| Granted 22,500 options to buy
@ $0.9, valued at
$20.3k
|
|
|
|
|